Insiders · HLXB

HLXB insider transactions

Helix Acquisition Corp. II (HLXB) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for HLXB

• 240d
  SEC Form 4 filed by Director Tipirneni Praveen P.

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 240d
  SEC Form 4 filed by Director Mccormick Frank

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 240d
  SEC Form 4 filed by Director Bauer Jake

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 240d
  SEC Form 4 filed by Chief Scientific Officer Beltran Pedro

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 240d
  SEC Form 4 filed by Chief Med & Dev Officer Ben Yong

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 240d
  SEC Form 4 filed by Chief Executive Officer Wallace Eli M.

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 240d
  SEC Form 4 filed by Chief Financial Officer Mehra Uneek

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 250d
  SEC Form 3 filed by new insider Tipirneni Praveen P.

  3 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 250d
  SEC Form 3 filed by new insider Doig Michelle

  3 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 250d
  SEC Form 3 filed by new insider Mccormick Frank

  3 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 250d
  New insider Bridgebio Pharma Llc claimed ownership of 13,805,126 shares (SEC Form 3)

  3 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 250d
  SEC Form 3 filed by new insider Bauer Jake

  3 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 250d
  SEC Form 3 filed by new insider Kumar Neil

  3 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 250d
  SEC Form 3 filed by new insider Ben Yong

  3 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 250d
  SEC Form 3 filed by new insider Wallace Eli M.

  3 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 250d
  SEC Form 3 filed by new insider Mehra Uneek

  3 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 250d
  SEC Form 3 filed by new insider Beltran Pedro

  3 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 256d
  Director Chen Bihua converted options into 4,172,126 shares, returned 152,940 shares to the company and was granted 10,950,408 shares (SEC Form 4)

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 257d
  SEC Form 3 filed by new insider Kelleher Raymond J.

  3 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 257d
  SEC Form 4 filed by Chief Legal Officer Obradovic Nebojsa

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 257d
  SEC Form 4 filed by Chief Financial Officer Tripp Caleb

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 257d
  Former Director Holman Albert A Iii converted options into 30,000 shares (SEC Form 4)

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 257d
  Former Director Mckenna Mark C. converted options into 30,000 shares (SEC Form 4)

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 257d
  Former Director Schmid John P. converted options into 30,000 shares (SEC Form 4)

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 438d
  SEC Form 3 filed by new insider Holman Albert A Iii

  3 - Helix Acquisition Corp. II (0001869105) (Issuer)
• 439d
  SEC Form 4 filed by Director Helix Holdings Ii Llc

  4 - Helix Acquisition Corp. II (0001869105) (Issuer)
• 439d
  SEC Form 4 filed by CEO and Chairperson Chen Bihua

  4 - Helix Acquisition Corp. II (0001869105) (Issuer)